Information For:

Manufacturers

Regulator

Healthcare

Consumers

Members

General Chapters Status

Last updated April 24, 2009

Chapter Title Expert Committee Liaison Official Status
<1> Injections PPI AHC@usp.org New in Development
<2> Default Conditions for Oral Solid Dosage Forms PDF AHC@usp.org New in Development
<3> PRODUCT QUALITY TESTS - TOPICAL AND TRANSDERMAL PRODUCTS
MRM@usp.org New in Development
<11> Reference Standards RS PSL@usp.org Official in PF
<16> Automated Methods Of Analysis GC HP@usp.org Official
<21> Thermometers GC AHC@usp.org Official
<31> Volumetric Apparatus GC HP@usp.org Official
<41> Weight and Balances GC HP@usp.org Official in PF
<51> Antimicrobial Effectiveness Testing MSA RST@USP.org Official
<55> Biological Indicators – Resistance Performance Tests MSA RST@usp.org Official
<61> Microbiological Examination Of Non–Sterile Products: Microbial Enumeration Tests (Harmonization) MSA RST@usp.org Official
<62> MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS; TESTS FOR SPECIFIED MICROORGANISMS (Harmonization) MSA RST@usp.org Official
<63> Mycoplasma Testing MSA RST@usp.org New in PF
<71> Sterility Tests MSA RST@usp.org  Official
<81> Antibiotics-Antimicrobial Assays MDANT AWW@usp.org Official
<85> Bacterial Endotoxins Test (Harmonization) MSA RST@usp.org  Official
<87> Biological Reactivity Tests, In Vitro GTMDB RST@usp.org Official
<88> Biological Reactivity Tests, In Vivo GTMDB RST@usp.org Official
<90> FETAL BOVINE SERUM FUNCTIONALITY TEST <90> FBS Quality Attributes and Functionality Tests BBCGT FA@usp.org New in development
<91> CALCIUM PANTOTHENATE ASSAY DSN CSP@usp.org Official
<92> Cytokines and Growth Factors Used as Ancillary Materials BBCGT FA@usp.org  New in Development
<111> Design and Analysis of Biological Assays STAT TSM@usp.org Revision in PF
<115> DEXPANTHENOL ASSAY DSN CSP@usp.org Official
<121> INSULIN ASSAYS BBPP TZS@usp.org Official
<123> Glucagon Bioassays  BBPP TZS@usp.org  New in Development
<124> EPOETIN BIOASSAYS BBPP TZS@usp.org New in Development
<126> Somatropin Bioassays  BBPP TZS@usp.org  New in Development
<130> Protein A Quality Attributes BBPP AEY@usp.org Official
<141> PROTEIN–BIOLOGICAL ADEQUACY TEST BBPP TZS@usp.org Official
<151> Pyrogen Test MSA RST@usp.org Official
<161> Transfusion And Infusion Assemblies And Similar Medical Devices GTMDB RST@usp.org Official
<162> Diphtheria Antitoxin Potency Test for Human Immunoglobulins BBBP AEY@usp.org New in Development
<165> Prekallikrein Activator Test for Human Plasma – Derived Products BBBP AEY@usp.org New in Development
<166> Test for Anticomplementary Activity of Human Immunoglobulins BBBP AEY@usp.org New in Development
<171> VITAMIN B12 ACTIVITY ASSAY DSN CSP@usp.org Official
<181> Identification–Organic Nitrogenous Bases GC AHC@usp.org Official
<191> Identification test – General GC AHC@usp.org Official
<193> IDENTIFICATION--TETRACYCLINES MDANT AWW@usp.org Official
<197> Spectrophotometric Identification Tests GC HP@usp.org Official in PF
<201> Thin–layer Chromatographic Identification Test GC HP@usp.org Official
<206> Aluminum GC KXZ@usp.org Official
<207> Test for 1,6 – Anhydro Derivate of Enoxaparin Sodium BBBP AEY@usp.org New in Development
<208> Anti – Factor Iia and Anti–Factor Xa Assays for Low Molecular Weight Heparins BBBP AEY@usp.org New in Development
<209> Low Molecular Weight Heparin Molecular Weight Determinations BBBP AEY@usp.org New in Development
<211> Arsenic GC KXZ@usp.org Official
<221> Chloride And Sulfate GC KXZ@usp.org Official
<223> DIMETHYLANILINE MDANT AWW@usp.org Official
<226> 4–EPIANHYDROTETRACYCLINE MDANT AWW@usp.org Official
<228> Ethylene Oxide and Dioxane EGC HW@usp.org  New in PF
<231> Heavy Metals (Harmonization) GC KXZ@usp.org Official
<241> Iron GC KXZ@usp.org Official
<251> Lead GC KXZ@usp.org Official
<261> Mercury GC KXZ@usp.org Official
<264> Nickel EGC HW@usp.org New in Development
<267> POROSIMETRY BY MERCURY INTRUSION (Harmonization) EGC KTM@usp.org New in PF
<271> Readily Carbonizable Substances Test GC AHC@usp.org Official
<291> Selenium GC KXZ@usp.org Official
<301> Acid–Neutralizing Capacity GC KXZ@usp.org Official
<311> ALGINATES ASSAY EGC RHL@usp.org Official
<331> AMPHETAMINE ASSAY MDPP RR@usp.org Official
<341> ANTIMICROBIAL AGENTS–CONTENT MDAA BD@usp.org Official
<351> ASSAY FOR STEROIDS MDPS DWV@usp.org Official
<361> BARBITURATE ASSAY MDPP RR@usp.org Official
<365> BIOTIN ASSAY DSN CSP@usp.org New in development
<367> CAROTENOID ANALYISIS DSN CSP@usp.org New in Development
<371> COBALAMIN RADIOTRACER ASSAY RMI RR@usp.org Official
<381> Elastomeric Closures For Injections PPI DGH@usp.org Official
<391> Epinephrine Assay AER KXZ@usp.org Official
<401> FATS AND FIXED OILS EGC HW@usp.org Official
<411> FOLIC ACID ASSAY DSN CSP@usp.org Official
<413> IMPURITIES TESTING IN MEDICAL GASES AER KXZ@usp.org New in development
<415> Medical Gases Assay AER KXZ@usp.org New in development
<425> IODOMETRIC ASSAY–ANTIBIOTICS MDANT AWW@usp.org Official
<429> Light Diffraction Measurement Of Particle Size (Harmonization) GC KXZ@usp.org Official
<431> METHOXY DETERMINATION EGC HW@usp.org Official
<441> NIACIN OR NIACINAMIDE ASSAY DSN CSP@usp.org Official
<451> Nitrite Titration GC AHC@usp.org Official
<461> Nitrogen Determination GC AHC@usp.org Official
<466> Ordinary Impurities GC AHC@usp.org  Official
<467> Residual Solvents GC HP@usp.org Official in PF
<471> Oxygen Flask Combustion GC HP@usp.org Official
<481> RIBOFLAVIN ASSAY DSN CSP@usp.org Official
<501> Salts Of Organic Nitrogenous Bases GC AHC@usp.org Official
<503> Acetic Acid in Peptides BBPP TZS@usp.org Official
<511> SINGLE–STEROID ASSAY MDPS DWV@usp.org Official
<521> SULFONAMIDES MDAA BD@usp.org Official
<525> SULFUR DIOXIDE EGC HW@usp.org Official
<531> THIAMINE ASSAY DSN CSP@usp.org Official
<541> Titrimetry GC HP@usp.org Official
<551> ALPHA TOCOPHEROL ASSAY DSN CSP@usp.org Official
<561> ARTICLES OF BOTANICAL ORIGIN DSGC YT@usp.org Official
<563> IDENTIFICATION OF ARTICLES OF BOTANICAL ORIGIN DSB MHS@usp.org Official
<565> BOTANICAL EXTRACTS DSB MHS@usp.org Official
<571> VITAMIN A ASSAY DSN CSP@usp.org Official
<581> VITAMIN D ASSAY DSN CSP@usp.org Official
<591> Zinc Determination GC KXZ@usp.org Official
<601> Aerosols, Nasal Sprays, Metered-Dose Inhalers and Dry Powder Inhalers AER KXZ@usp.org Official
<611> Alcohol Determination GC HP@usp.org Official
<616> BULK DENSITY AND TAPPED DENSITY (Harmonization) EGC KTM@usp.org Official
<621> Chromatography GC HP@usp.org Official in PF
<631> Color and Achromicity GC AHC@usp.org Official
<641> Completeness of Solution GC AHC@usp.org Official
<643> Total Organic Carbon PW AHC@usp.org Official
<644> Conductivity (Harmonization) GC AHC@usp.org New in Development
<645> Water Conductivity PW AHC@usp.org Official
<651> CONGEALING TEMPERATURE EGC HW@usp.org Official
<659> Preservation, Packaging, Storage and Labeling PS DGH@usp.org New in Development
<660> Containers – Glass PS DGH@usp.org Official
<661> Containers – Plastic PS DGH@usp.org Official
<662> Containers – Metal PS DGH@usp.org New in Development
<670> Containers – Auxiliary Components PS DGH@usp.org New in PF
<671> Containers – Performance Testing PS DGH@usp.org Official
<681> Repackaging into Single–Unit Containers and Unit–Dose Containers for Nonsterile solid and Liquid Dosage Forms PS DGH@usp.org Official
<691> Cotton GTMDB RST@usp.org Official
<695> Crystallinity GC KXZ@usp.org Official
<696> Crystallinity Determination By Solution Calorimetry (Harmonization) GC KXZ@usp.org Official
<698> Deliverable Volume PDF WEB@usp.org Official
<699> DENSITY OF SOLIDS (Harmonization) EGC KTM@usp.org Official
<701> Disintegration (Harmonization Stage 6) BPC WEB@usp.org Official
<711> Dissolution (Harmonization Stage 6) BPC WEB@usp.org Official in PF
<721> Distilling Range GC AHC@usp.org Official
<724> Drug Release BPC WEB@usp.org Official
<725> PRODUCT PERFORMANCE TESTS - TOPICAL AND TRANSDERMAL PRODUCTS BPC WEB@usp.org New in Development
<726> Electrophoresis GC KXZ@usp.org Official
<727> Capillary Electrophoresis GC KXZ@usp.org Official
<729> Globule Size Distribution In Lipid Injectable Emulsions PPI DGH@usp.org Official
<730> Plasma Spectrochemistry GC KXZ@usp.org Official
<731> Loss on Drying GC HP@usp.org Official
<733> Loss on Ignition GC HP@usp.org Official
<736> Mass Spectrometry GC KXZ@usp.org Official
<741> Melting Range or Temperature GC AHC@usp.org Official
<751> METAL PARTICLES IN OPHTHALMIC OINTMENTS PPI DGH@usp.org Official
<755> Minimum Fill PS DGH@usp.org Official
<761> Nuclear Magnetic Resonance GC KXZ@usp.org Official
<771> OPHTHALMIC OINTMENTS PPI DGH@usp.org Official
<776> Optical Microscopy GC AHC@usp.org Official
<781> Optical Rotation GC AHC@usp.org Official
<785> Osmolality And Osmolarity GC HP@usp.org Official
<786> PARTICLE SIZE DISTRIBUTION ESTIMATION BY ANALYTICAL SIEVING (Harmonization) EGC KTM@usp.org Official
<788> Particulate Matter In Injections (Harmonization) PPI DGH@usp.org Official
<789> Particulate Matter In Ophthalmic Solutions PPI DGH@usp.org Official
<791> pH GC AHC@usp.org Official
<795> PHARMACEUTICAL COMPOUNDING–NONSTERILE PREPARATIONS CRX RXS@usp.org Official
<797> PHARMACEUTICAL COMPOUNDING–STERILE PREPARATIONS SCC SCB@usp.org Official
<801> Polarography GC AHC@usp.org Official
<811> POWDER FINENESS (Harmonization) EGC KTM@usp.org Official
<821> RADIOACTIVITY RMI RR@usp.org Official
<823> RADIOPHARMACEUTICALS FOR POSITRON EMISSION TOMOGRAPHY–COMPOUNDING RMI RR@usp.org Official
<831> Refractive Index GC AHC@usp.org Official
<841> Specific Gravity GC AHC@usp.org Official
<846> Specific Surface Area (Harmonization) GC KXZ@usp.org Official
<851> Spectrophotometry And Light–Scattering GC HP@usp.org Official in PF
<853> Fluorescence Spectroscopy GC HP@usp.org New in PF
<854> Mid-Infrared Spectroscopy GC HP@usp.org New in PF
<857> UV–Visible spectroscopy GC HP@usp.org New in PF
<858> Vibrational Spectroscopic Imaging GC HP@usp.org New in Development
<861> Sutures–Diameter GTMDB RST@usp.org Official
<871> Sutures–Needle Attachment GTMDB RST@usp.org Official
<881> Tensile Strength GTMDB RST@usp.org Official
<891> Thermal Analysis GC AHC@usp.org Official
<905> Uniformity Of Dosage Units (Harmonization) PDF WEB@usp.org Official in PF
<909> Uniformity of Liquids, Injections, And Topicals PDF WEB@usp.org New in Development
<911> Viscosity EGC HW@usp.org Official
<912> NON-NEWTONIAN RHEOLOGY EGC HW@usp.org New in PF
<921> Water Determination GC AHC@usp.org Official
<941> X–Ray Diffraction (Harmonization) GC HP@usp.org Official
<943> X–Ray Diffraction – Solids GC HP@usp.org New in Development
<1005> Acoustic Emission GC HP@usp.org Official
<1010> Analytical Data – Interpretation And Treatment STAT HP@usp.org Official
<1015> AUTOMATED RADIOCHEMICAL SYNTHESIS APPARATUS RMI RR@usp.org Official
<1021> Barrier Technologies MSA RST@usp.org New in Development
<1024> Bovine Serum BBCGT FA@usp.org New in development
<1027> Flow Cytometry BBCGT FA@usp.org New in development
<1028>PARTICLE SIZE MEASUREMENT EGC HW@usp.org New in Development
<1031> The Biocompatibility Of Materials Used In Drug Containers, Medical Devices, And Implants GTMDB RST@usp.org Official
<1032> DESIGN AND DEVELOPMENT OF BIOASSAYS BBPP TSM@usp.org New in Development
<1033> Biological Assay Validation STAT TSM@usp.org PF35(2)
<1035> Biological Indicators For Sterilization MSA RST@usp.org Official
<1036> Biological Indicators For Chemical Sterilization MSA RST@usp.org New in Development
<1039> Chemometrics: Multivariate Analysis GC HP@usp.org New in Development
<1041> BIOLOGICS BBPP AK@usp.org Official
<1043> ANCILLARY MATERIALS FOR CELL, GENE AND TISSUE ENGINEERED PRODUCTS BBCGT AEY@usp.org Official
<1045> BIOTECHNOLOGY–DERIVED ARTICLES BBPP AK@usp.org Official
<1046> CELL THERAPY PRODUCTS BBCGT FA@usp.org Official
<1047> GENE THERAPY PRODUCTS BBCGT FA@usp.org New in Development
<1048> QUALITY OF BIOTECHNOLOGICAL PRODUCTS: ANALYSIS OF THE EXPRESSION CONSTRUCT IN CELLS USED FOR PRODUCTION OF r–DNA DERIVED PROTEIN PRODUCTS BBPP AK@usp.org Official
<1049> QUALITY OF BIOTECHNOLOGICAL PRODUCTS: STABILITY TESTING OF BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS BBPP AK@usp.org Official
<1050> VIRAL SAFETY EVALUATION OF BIOTECHNOLOGY PRODUCTS DERIVED FROM CELL LINES OF HUMAN OR ANIMAL ORIGIN BBVV TZS@usp.org Official
<1051> Cleaning Glass Apparatus GC AHC@usp.org Official
<1052> BIOTECHNOLOGY–DERIVED ARTICLES – AMINO ACID ANALYSIS BBPP AK@usp.org Official
<1053> BIOTECHNOLOGY–DERIVED ARTICLES – CAPILLARY ELECTROPHORESIS BBPP AK@usp.org Official
<1054> BIOTECHNOLOGY–DERIVED ARTICLES – ISOELECTRIC FOCUSING BBPP AK@usp.org Official
<1055> BIOTECHNOLOGY–DERIVED ARTICLES – PEPTIDE MAPPING BBPP AK@usp.org Official
<1056> BIOTECHNOLOGY–DERIVED ARTICLES – POLYACRYLAMIDE GEL ELECTROPHORESIS BBPP AK@usp.org Official
<1057> BIOTECHNOLOGY–DERIVED ARTICLES – TOTAL PROTEIN ASSAY BBPP AK@usp.org Official
<1058> Analytical Instrument Qualification GC HP@usp.org Official
<1059> EXCIPIENT PERFORMANCE EGC RHL@usp.org New in Development
<1061> Color – Instrument Measurement (Harmonization Stage 3 – Regulatory Consultation and Discussion) GC AHC@usp.org Official
<1062> COMPACTABILITY TEST EGC HW@usp.org New in Development
<1065> Ion Chromatography GC HP@usp.org Official
<1066> Physical Environments that promote safe medication use SMU CYB@usp.org New in PF
<1070> Emergency Medical Services Vehicles And Ambulances – Storage Of Preparations PS DGH@usp.org Official
<1072> Disinfectants And Antiseptics MSA RST@usp.org Official
<1073> Effusivity GC HP@usp.org New in PF
<1074> Excipient Biological Safety Evaluation Guidelines GTMDB RST@usp.org Official
<1075> GOOD COMPOUNDING PRACTICES CRX RXS@usp.org Official
<1078> GOOD MANUFACTURING PRACTICES FOR BULK PHARMACEUTICAL EXCIPIENTS EGC RHL@usp.org Official
<1079> Good Storage And Shipping Practices PS DGH@usp.org Official
<1080> BULK PHARMACEUTICAL EXCIPIENTS–CERTIFICATE OF ANALYSIS EGC RHL@usp.org Official
<1081> GEL STRENGTH OF GELATIN EGC HW@usp.org Official
<1082> Genotoxicity Testing GTMDB RST@usp.org New in Development
<1084> GLYCOPROTEIN AND GLYCAN ANALYSIS – Introduction and Choice of Analysis Strategies BBPP AK@usp.org New in development
<1085> GLYCOPROTEIN AND GLYCAN ANALYSIS – DEGLYCOSYLATION OF GLYCOPROTEINS BBPP AK@usp.org New in Development
<1086> Impurities in Official Articles GC AHC@usp.org Official
<1087> Apparent Intrinsic Dissolution BPC WEB@usp.org Official
<1088> In Vitro and In Vivo Evaluation Of Dosage Forms BPC WEB@usp.org Official
<1090> In Vivo Bioequivalence Guidance BPC WEB@usp.org Official in PF
<1091> LABELING OF INACTIVE INGREDIENTS NOM AW@usp.org Official
<1092> The Dissolution Procedure. Development And Validation. BPC WEB@usp.org Official
<1094> GLYCOPROTEIN AND GLYCAN ANALYSIS – MONOSACCHARIDE ANALYSIS BBPP AK@usp.org New in Development
<1095> GLYCOPROTEIN AND GLYCAN ANALYSIS – OLIGOSACCHARIDE ANALYSIS BBPP AK@usp.org New in Development
<1097> Bulk Powder Sampling Procedures STAT HP@usp.org New in PF
<1098> Validation of Research Test kits BBCGT FA@usp.org New in development
<1101> Medicine Dropper PDF WEB@usp.org Official
<1102> Immunological Test Methods – General Considerations  BBVV AK@usp.org New in Development
<1103> Immunological Test Methods – ELISA  BBVV AK@usp.org New in Development
<1104> Immunological Test Methods – Western Blotting  BBVV AK@usp.org New in Development
<1105> Immunological Test Methods – Surface Plasmon Resonance  BBVV AK@usp.org New in Development
<1111> Microbiological Examination of Non-Sterile Products; Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use (Harmonization) MSA RST@usp.org Official
<1112> Microbiological Attributes of Nonsterile Pharmaceutical Products – Application of Water Activity Determination MSA RST@usp.org Official
<1113> Microbial Identification MSA RST@usp.org New in PF
<1116> Microbiological Evaluation of Clean Rooms and Other Controlled Environments MSA RST@usp.org Official
<1117> Microbiological Best Laboratory Practices MSA RST@usp.org Official
<1118> Monitoring Devices – Time, Temperature, And Humidity PS DGH@usp.org Official
<1119> Near–Infrared Spectrophotometry GC HP@usp.org Official
<1120> Raman Spectrophotometry GC HP@usp.org Official
<1121> NOMENCLATURE NOM AW@usp.org Official
<1125> NUCLEIC ACID-BASED TECHNIQUES – GENERAL BBVV AEY@usp.org Official
<1126> NUCLEIC ACID-BASED TECHNIQUES – Extraction, DETECTION, AND SEQUENCING BBVV AEY@usp.org Official
<1127> NUCLEIC ACID-BASED TECHNIQUES – AMPLIFICATION BBVV AEY@usp.org Official
<1128> NUCLEIC ACID-BASED TECHNICQUES - MICROARRAYS BBVV AEY@usp.org New in Development
<1129> NUCLEIC ACID-BASED TECHNIQUES –Genotyping BBVV AEY@usp.org Official
<1130> NUCLEIC ACID-BASED TECHNIQUES – APPROACHES FOR DETECTING TRACE NUCLEIC ACIDS (RESIDUAL DNA TESTING) BBVV AEY@usp.org Official
<1136> Packaging – Unit Of Use PS DGH@usp.org Official
<1146> Packaging Practice–Repackaging a Single Solid Oral Drug Product Into a Unit–Dose Container PS DGH@usp.org Official
<1150> Pharmaceutical Stability PS DGH@usp.org Official
<1151> Pharmaceutical Dosage Forms PDF WEB@usp.org Official
<1160> PHARMACEUTICAL CALCULATIONS IN PRESCRIPTION COMPOUNDING CRX RXS@usp.org Official
<1163> Quality Assurance in Pharmaceutical Compounding  CRX RXS@usp.org Official
<1165> RADIOPHARMACEUTICALS QUALITY ASSURANCE – COMPOUNDING RMI RR@usp.org New in Development
<1171> Phase–Solubility Analysis GC HP@usp.org Official
<1174> POWDER FLOW (Harmonization) EGC KTM@usp.org Official
<1175> Preformulation Guidelines PS DGH@usp.org New in Development
<1176> PRESCRIPTION BALANCES AND VOLUMETRIC APPARATUS CRX RXS@usp.org Official
<1177> Good Packaging Practices PS DGH@usp.org Official
<1180> Human Plasma BBBP AEY@usp.org New in Development
<1181> Scanning Electron Microscopy GC KXZ@usp.org Official
<1184> Sensitization Testing GTMDB RST@usp.org Official
<1191> Stability Considerations In Dispensing Practice PS DGH@usp.org Official
<1195> SIGNIFICANT CHANGE GUIDE FOR BULK PHARMACEUTICAL EXCIPIENTS EGC RHL@usp.org Official
<1196> PHARMACOPEIAL HARMONIZATION HDQ KTM@usp.org Official
<1197> GOOD DISTRIBUTION PRACTICES FOR PHARMACEUTICAL GRADE EXCIPIENTS EGC RHL@usp.org New in Development
<1207> Sterile Product Packaging–Integrity Evaluation MSA RST@usp.org Official
<1208> Sterility Testing – Validation of Isolator Systems MSA RST@usp.org Official
<1209> Sterilization–Chemical And Physicochemical Indicators And Integrators MSA RST@usp.org Official
<1211> Sterilization and Sterility Assurance of Compendial Articles MSA RST@usp.org Official
<1216> Tablet Friability (Harmonization) PDF WEB@usp.org Official
<1217> Tablet Breaking Force PDF WEB@usp.org Official
<1221> Teaspoon PS DGH@usp.org Official
<1222> Terminally Sterilized Pharmaceutical Products – Parametric Release MSA RST@usp.org Official
<1223> Validation Of Alternative Microbiological Methods MSA RST@usp.org Official
<1224> Validation of Aseptic Processes MSA RST@usp.org New in Development
<1225> Validation of Compendial Procedures GC HP@usp.org Official in PF
<1226> Verification of Compendial Procedures GC HP@usp.org Official
<1227> Validation of Microbial Recovery from Pharmacopeial Articles MSA RST@usp.org Official
<1228> PROCESS CHARACTERIZATION AND VALIDATION FOR PROTEIN PRODUCTS BBPP AK@usp.org New in Development
<1229> Sterilization – General Concepts MSA RST@usp.org New in Development
<1230> Water for Health Applications PW AHC@usp.org Official
<1231> Water for Pharmaceutical Purposes PW AHC@usp.org Official
<1232> Instrumentation for Analysis of High Purity Pharmaceutical Waters PW AHC@usp.org New in Development
<1235> VACCINES FOR HUMAN USE BBVV FA@usp.org In PF
<1236> VETERINARY BIOPHARMACEUTICS CLASSIFICATION SYSTEM VET EG@usp.org New in Development
<1237> VIROLOGY TEST METHODS BBVV FA@usp.org Balloted
<1238> Vaccines for Human Use – Bacterial Vaccines BBVV TZS@usp.org New in Development
<1239> Vaccines for Human Use – Viral Vaccines BBVV TZS@usp.org New in Development
<1240> Viral Testing for Blood and Blood Products BBVV AEY@usp.org New in Development
<1241> Water–Solid Interactions In Pharmaceutical Systems (Harmonization) GC AHC@usp.org New in Development
<1251> Weighing on an Analytical Balance GC HP@usp.org Official in PF
<1260> MONOCLONAL ANTIBODIES BBPP AEY@usp.org New in Development
<1265> Written Prescription Drug Information – Guidelines PS DGH@usp.org Official
<281> Residue On Ignition (Harmonization) GC HP@usp.org Official
<1788> Particulate Matter Determination in Parenteral and Ophthalmic Products PPI DGH@usp.org New in development
<2021>MICROBIAL ENUMERATION TESTS–NUTRITIONAL AND DIETARY SUPPLEMENTS MSA RST@usp.org Official
<2022>MICROBIOLOGICAL PROCEDURES FOR ABSENCE OF SPECIFIED MICROORGANISMS–NUTRITIONAL AND DIETARY SUPPLEMENTS MSA RST@usp.org Official
<2023>MICROBIOLOGICAL ATTRIBUTES OF NONSTERILE NUTRITIONAL AND DIETARY SUPPLEMENTS MSA RST@usp.org Official
<2030> SUPPLEMENTAL INFORMATION FOR ARTICLES OF BOTANICAL ORIGIN DSGC/DSI YT@usp.org / DNS@usp.org Official
<2040> DISINTEGRATION AND DISSOLUTION OF DIETARY SUPPLEMENTS DSPS ND@usp.org Official in PF
<2091> WEIGHT VARIATION OF DIETARY SUPPLEMENTS DSGC YT@usp.org Official
<2750> MANUFACTURING PRACTICES FOR DIETARY SUPPLEMENTS DSGC YT@usp.org Revision Proposed
<345> Assay for Citric Acid/Citrate and Phosphate GC KXZ@usp.org  Official
<1229D> Dry Heat Sterilization MSA RST@usp.org New in Development
<1229E> Ethylene Oxide Sterilization MSA RST@usp.org New in Development
<1229F> Filtration Sterilization MSA RST@usp.org New in Development
<1229R> Radiation Sterilization MSA RST@usp.org New in Development
<1229S> Steam Sterilization MSA RST@usp.org New in Development
<2xxx> Irradiation Assays DSGC YT@usp.org New in Development
<2xxx> Supplements Adulteration with Drugs DSGC YT@usp.org New in Development


* N.B. – Because of the ongoing nature of General Chapter development and revision, the information in this table is subject to change and should be regarded as a close approximation of current status.

Expert Committees

AER = Aerosols
BBBP = Biologics and Biotechnology Blood and Blood Products
BBCGT = Biologics and Biotechnology Cell and Gene Therapy
BBPP = Biologics and Biotechnology Proteins and Polysaccharides
BBVV = Biologics and Biotechnology Vaccines and Virology
BPC = Biopharmaceutics
CRX = Compounding Pharmacy
DSB = Dietary Supplements–Botanicals
DSGC = Dietary Supplements General Chapters
DSI = Dietary Supplements–Information
DSN = Dietary Supplements–Nonbotanicals, Nutrition and Electrolytes
DSPS = Dietary Supplements–Performance Standards
EGC = Excipient General Chapters
GC = General Chapters
GTMDB = General Toxicity and Medical Device Biocompatibility
HDQ = Headquarters
MDAA = Monograph Development: Antivirals and Antimicrobials
MDANT = Monograph Development: Antibiotics
MDPP = Monograph Development: Psychiatrics and Psychoactives
MDPS = Monograph Development: Pulmonary and Steroids
MSA = Microbiology and Sterility Assurance
NOM = Nomenclature
PDF = Pharmaceutical Dosage Forms
PPI = Parenteral Products–Industrial
PS = Packaging and Storage
PW = Pharmaceutical Waters
RMI = Radiopharmaceuticals and Medical Imaging Agents
RS = Reference Standards
SCC = Sterile Compounding
SMU = Safe Medication Use
STAT = Statistics

Liaisons
AEY = Anita Szajek
AHC = Antonio Hernandez–Cardoso
AK = Alexey Khrenov
AW= Andrzej Wilk
AWW = Ahayla Wise
BD = Benham Devani
CSP = Curtis Phinney
CYB = Colleen Brennan
DGH = Desmond Hunt
DNS = Dan Sharma
DWV = Domenick Vicchio
EG = Elena Gonikberg
FA = Fouad Atouf
HP = Horacio Pappa
HW = Hong Wang
KTM = Kevin Moore
KXZ = Kahkashan Zaidi
MHS = Maged Sharaf
ND = Natalia Davydova
PSL = Steve Lane
RR = Ravi Ravichandran
RHL = Robert Lafaver
RXS = Rick Schnatz
RST = Radha Tirumalai
SCB = Shawn Becker
TSM = Tina Morris
TZS = Tom Sigambris
WEB = William Brown
YT = Yoshi Tokiwa